Pharmaceuticals
14 published profiles.
Most companies here were classified from the code a registry recorded when they were registered. Those codes are often decades old and may not describe what the company does today. Each profile states which of its industries came from a registry code.
- AbbVie Inc.listedUS-DEPharmaceuticals$325B Public float · as of 2025-06-30CIK 1551152
- Abbott LaboratoriesABBOTT LABORATORIESlistedUS-ILPharmaceuticals$232B Public float · as of 2025-06-30CIK 1800
- Amgen IncAMGEN INClistedUS-DEPharmaceuticals$150B Public float · as of 2025-06-30CIK 318154
- Bristol Myers Squibb CoBRISTOL MYERS SQUIBB COlistedUS-DEPharmaceuticals$94.2B Public float · as of 2025-06-30CIK 14272
- ELI LILLY & ColistedUS-INPharmaceuticals$808B Public float · as of 2025-06-30CIK 59478
- Gilead Sciences, Inc.GILEAD SCIENCES, INC.listedUS-DEPharmaceuticals$103B Public float · as of 2025-06-30CIK 882095
- Johnson & JohnsonJOHNSON & JOHNSONlistedUS-NJPharmaceuticals$367B Public float · as of 2025-06-29CIK 200406
- Merck & Co., Inc.listedUS-NJPharmaceuticals$198B Public float · as of 2025-06-30CIK 310158
- Moderna, Inc.listedUS-DEPharmaceuticals$9.9B Public float · as of 2025-06-30CIK 1682852
- Novo Nordisk A SNOVO NORDISK A SlistedUSPharmaceuticalsCIK 353278
- Pfizer IncPFIZER INClistedUS-DEPharmaceuticals$138B Public float · as of 2025-06-29CIK 78003
- Regeneron Pharmaceuticals, Inc.REGENERON PHARMACEUTICALS, INC.listedUS-NYPharmaceuticals$54.8B Public float · as of 2025-06-30CIK 872589
- Takeda Pharmaceutical Co LtdTAKEDA PHARMACEUTICAL CO LTDlistedUSPharmaceuticalsCIK 1395064
- Vertex Pharmaceuticals Inc / MAVERTEX PHARMACEUTICALS INC / MAlistedUS-MAPharmaceuticals$113B Public float · as of 2025-06-30CIK 875320
| Company | Valuation | Jurisdiction | Industry | Status |
|---|---|---|---|---|
| AbbVie Inc. | $325B | US-DE listed | Pharmaceuticals | Unknown |
| Abbott Laboratories ABBOTT LABORATORIES | $232B | US-IL listed | Pharmaceuticals | Unknown |
| Amgen Inc AMGEN INC | $150B | US-DE listed | Pharmaceuticals | Unknown |
| Bristol Myers Squibb Co BRISTOL MYERS SQUIBB CO | $94.2B | US-DE listed | Pharmaceuticals | Unknown |
| ELI LILLY & Co | $808B | US-IN listed | Pharmaceuticals | Unknown |
| Gilead Sciences, Inc. GILEAD SCIENCES, INC. | $103B | US-DE listed | Pharmaceuticals | Unknown |
| Johnson & Johnson JOHNSON & JOHNSON | $367B | US-NJ listed | Pharmaceuticals | Unknown |
| Merck & Co., Inc. | $198B | US-NJ listed | Pharmaceuticals | Unknown |
| Moderna, Inc. | $9.9B | US-DE listed | Pharmaceuticals | Unknown |
| Novo Nordisk A S NOVO NORDISK A S | Not available | US listed | Pharmaceuticals | Unknown |
| Pfizer Inc PFIZER INC | $138B | US-DE listed | Pharmaceuticals | Unknown |
| Regeneron Pharmaceuticals, Inc. REGENERON PHARMACEUTICALS, INC. | $54.8B | US-NY listed | Pharmaceuticals | Unknown |
| Takeda Pharmaceutical Co Ltd TAKEDA PHARMACEUTICAL CO LTD | Not available | US listed | Pharmaceuticals | Unknown |
| Vertex Pharmaceuticals Inc / MA VERTEX PHARMACEUTICALS INC / MA | $113B | US-MA listed | Pharmaceuticals | Unknown |